| scholarly article | Q13442814 |
| P2093 | author name string | Hui Jiang | |
| Xiaoyi Huang | |||
| Na Ta | |||
| Jianming Zheng | |||
| Yisha Gao | |||
| Xiaosong Zhi | |||
| P2860 | cites work | Genome-wide screening and identification of long noncoding RNAs and their interaction with protein coding RNAs in bladder urothelial cell carcinoma | Q87622177 |
| Increased expression of the lncRNA PVT1 is associated with poor prognosis in pancreatic cancer patients | Q95605752 | ||
| Initial sequencing and analysis of the human genome | Q21045365 | ||
| A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex | Q22009369 | ||
| Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33 | Q23924183 | ||
| OS-9 interacts with hypoxia-inducible factor 1alpha and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1alpha | Q24295172 | ||
| Distinct RNA motifs are important for coactivation of steroid hormone receptors by steroid receptor RNA activator (SRA). | Q24541490 | ||
| The Bcl-2 apoptotic switch in cancer development and therapy | Q24620437 | ||
| The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r | Q24633774 | ||
| Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs | Q24673619 | ||
| Molecular Targeted Intervention for Pancreatic Cancer | Q26798453 | ||
| Long noncoding RNAs: past, present, and future | Q26991873 | ||
| The emergence of lncRNAs in cancer biology | Q27024237 | ||
| Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis | Q28140740 | ||
| Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase | Q28141044 | ||
| The H19 locus acts in vivo as a tumor suppressor | Q28508794 | ||
| A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression | Q29614326 | ||
| Angiogenesis: an organizing principle for drug discovery? | Q29614538 | ||
| MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer | Q29620125 | ||
| The NDC80 complex proteins Nuf2 and Hec1 make distinct contributions to kinetochore–microtubule attachment in mitosis | Q30498704 | ||
| Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells | Q33350623 | ||
| Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis | Q33479445 | ||
| Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells | Q33556150 | ||
| Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung | Q33606248 | ||
| Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer | Q33613022 | ||
| Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer | Q33688617 | ||
| DD3: a new prostate-specific gene, highly overexpressed in prostate cancer | Q33884277 | ||
| Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia | Q34038562 | ||
| Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA | Q34185076 | ||
| Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer | Q34314018 | ||
| Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients | Q34376920 | ||
| Photothermal Treatment of Human Pancreatic Cancer Using PEGylated Multi-Walled Carbon Nanotubes Induces Apoptosis by Triggering Mitochondrial Membrane Depolarization Mechanism | Q34440581 | ||
| PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy | Q34611796 | ||
| Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters | Q34629890 | ||
| Can urinary PCA3 supplement PSA in the early detection of prostate cancer? | Q34692263 | ||
| Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy | Q34792453 | ||
| Oncofetal H19 RNA promotes tumor metastasis | Q39007631 | ||
| Downregulation of gas5 increases pancreatic cancer cell proliferation by regulating CDK6. | Q39096980 | ||
| Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer | Q39145196 | ||
| Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma | Q39230141 | ||
| Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy | Q39329786 | ||
| Downregulation of NUF2 inhibits tumor growth and induces apoptosis by regulating lncRNA AF339813. | Q40927291 | ||
| A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV. | Q41743831 | ||
| Targeting the hypoxia pathway to treat pancreatic cancer | Q42642233 | ||
| Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer | Q44042796 | ||
| Long non-coding RNAs expressed in pancreatic ductal adenocarcinoma and lncRNA BC008363 an independent prognostic factor in PDAC. | Q44140426 | ||
| A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk | Q44178438 | ||
| Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1). | Q45019065 | ||
| Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers | Q51856604 | ||
| Natural antisense transcripts of hypoxia-inducible factor 1alpha are detected in different normal and tumour human tissues | Q52111744 | ||
| Hints of a language in junk DNA. | Q52365394 | ||
| Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer | Q53166363 | ||
| Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer | Q53215067 | ||
| Tumour-suppressor activity of H19 RNA | Q59071440 | ||
| Genomic Imprinting of IGF-II and H19 in Adult Human Pancreatic Tissues | Q60609534 | ||
| Mining treasures from 'junk DNA' | Q71609091 | ||
| The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer | Q81377177 | ||
| Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3; a systematic analysis of expert opinion | Q84484256 | ||
| Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer | Q86030438 | ||
| Immunotherapy improves overall survival in pancreatic cancer | Q86558451 | ||
| siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo | Q34951877 | ||
| The functional role of long non-coding RNA in human carcinomas | Q34995156 | ||
| Is "junk" DNA mostly intron DNA? | Q35030102 | ||
| H19 and Igf2--enhancing the confusion? | Q35031144 | ||
| The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer | Q35212896 | ||
| Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner | Q35238513 | ||
| Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16. | Q35443085 | ||
| Long noncoding RNA MALAT-1 enhances stem cell-like phenotypes in pancreatic cancer cells | Q35585395 | ||
| High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma | Q35690027 | ||
| Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer | Q35764908 | ||
| Detection of oncofetal h19 RNA in rheumatoid arthritis synovial tissue | Q35792008 | ||
| The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration. | Q35793635 | ||
| H19-Promoter-Targeted Therapy Combined with Gemcitabine in the Treatment of Pancreatic Cancer | Q36021781 | ||
| VEGF as a key mediator of angiogenesis in cancer | Q36319024 | ||
| HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. | Q36357062 | ||
| Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers | Q36546434 | ||
| ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer | Q36738916 | ||
| Hypoxia-induced lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923/KRAS pathway | Q36905828 | ||
| EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer | Q36998193 | ||
| Epigenetic Regulation of SOX9 by the NF-κB Signaling Pathway in Pancreatic Cancer Stem Cells | Q37179115 | ||
| Salivary HOTAIR and PVT1 as novel biomarkers for early pancreatic cancer | Q37295361 | ||
| Perineural invasion and associated pain in pancreatic cancer | Q37937421 | ||
| Prognostic factors related with survival in patients with pancreatic adenocarcinoma | Q38242807 | ||
| Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer | Q38299502 | ||
| The role of S100 proteins and their receptor RAGE in pancreatic cancer | Q38598852 | ||
| CA 19-9: Biochemical and Clinical Aspects | Q38623677 | ||
| Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver | Q38873616 | ||
| Long noncoding RNA, CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression | Q38880553 | ||
| Opposing Roles for the lncRNA Haunt and Its Genomic Locus in Regulating HOXA Gene Activation during Embryonic Stem Cell Differentiation | Q38884896 | ||
| Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer | Q38931711 | ||
| A novel long non-coding RNA ENST00000480739 suppresses tumour cell invasion by regulating OS-9 and HIF-1α in pancreatic ductal adenocarcinoma. | Q38947984 | ||
| Elevated expression level of long noncoding RNA MALAT-1 facilitates cell growth, migration and invasion in pancreatic cancer | Q38951842 | ||
| H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. | Q38985755 | ||
| Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues | Q38996378 | ||
| P275 | copyright license | Creative Commons Attribution 2.5 Generic | Q18810333 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic cancer | Q212961 |
| pancreatic neoplasm | Q7130412 | ||
| long non-coding RNA | Q15087973 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P577 | publication date | 2016-07-12 | |
| 2016-08-30 | |||
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | LncRNAs in pancreatic cancer |
| Q51319949 | A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane-treated colon cancer cells. |
| Q39152619 | Early detection of pancreatic cancer: Where are we now and where are we going? |
| Q33553830 | Gemcitabine Conjugated Chitosan and Double Antibodies (Abc-GC-Gemcitabine Nanoparticles) Enhanced Cytoplasmic Uptake of Gemcitabine and Inhibit Proliferation and Metastasis In Human SW1990 Pancreatic Cancer Cells |
| Q92996884 | Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma |
| Q98499749 | LINC00671 suppresses cell proliferation and metastasis in pancreatic cancer by inhibiting AKT and ERK signaling pathway |
| Q89533269 | Linc00261 inhibits metastasis and the WNT signaling pathway of pancreatic cancer by regulating a miR‑552‑5p/FOXO3 axis |
| Q55086969 | Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway. |
| Q92073717 | LncRNAs in ocular neovascularizations |
| Q50109077 | Long non-coding RNA H19 promotes proliferation and invasion in human glioma cells by downregulating miR-152. |
| Q92133481 | Long non-coding RNA HULC as a diagnostic and prognostic marker of pancreatic cancer |
| Q93129272 | Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression |
| Q49378570 | Long non-coding RNA XIST exerts oncogenic functions in pancreatic cancer via miR-34a-5p |
| Q47130796 | Meta-analysis of the clinical value of abnormally expressed long non-coding RNAs for pancreatic cancer |
| Q41721796 | Microarray Analysis of the Expression Profile of Long Non-Coding RNAs Indicates lncRNA RP11-263F15.1 as a Biomarker for Diagnosis and Prognostic Prediction of Pancreatic Ductal Adenocarcinoma |
| Q61799422 | Overexpressed long noncoding RNA TUG1 affects the cell cycle, proliferation, and apoptosis of pancreatic cancer partly through suppressing RND3 and MT2A |
| Q64233736 | Role of HDAC1 in the progression of gastric cancer and the correlation with lncRNAs |
| Q98289784 | Silencing of HIF-1α inhibited the expression of lncRNA NEAT1 to suppress development of hepatocellular carcinoma under hypoxia |
| Q58600724 | The Long Noncoding RNA HOST2 Promotes Gemcitabine Resistance in Human Pancreatic Cancer Cells |
| Q89853330 | The lncRNA ENSG00000254041.1 promotes cell invasiveness and associates with poor prognosis of pancreatic ductal adenocarcinoma |
| Q50129785 | The lncRNA-HOXA-AS2/EZH2/LSD1 oncogene complex promotes cell proliferation in pancreatic cancer |
| Q89638297 | The multifaceted roles of long noncoding RNAs in pancreatic cancer: an update on what we know |
| Q64905818 | The targeting of non‑coding RNAs by curcumin: Facts and hopes for cancer therapy (Review). |
| Q61451193 | Transcriptome analysis of pancreatic cancer cell response to treatment with grape seed proanthocyanidins |
| Q47145983 | lncRNA MALAT1, HOTTIP and PVT1 as predictors for predicting the efficacy of GEM based chemotherapy in first-line treatment of pancreatic cancer patients |
Search more.